Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 Jun;5(6):647–651. doi: 10.1128/aac.5.6.647

Effect of Clindamycin on Acute and Chronic Toxoplasmosis in Mice

Fausto G Araujo 1, Jack S Remington 1
PMCID: PMC429028  PMID: 15825419

Abstract

The effect of clindamycin on survival of mice during acute infection with the RH and C56 strains of Toxoplasma and the ability of this drug to prevent congenital transmission during the acute stage of the infection in the mother and to eradicate the parasite from tissues of mice chronically infected with the C56 strain were evaluated. The drug effectively prevented death due to the acute infection and, in the experimental model employed, eradicated the organism at least from the liver, spleen, and brain of approximately 30 to 50% of the acutely infected animals which survived. Clindamycin also effectively prevented congenital transmission during the acute infection in the mother. During short-term treatment (7 days), persistent parasitemia in the chronic infection was effectively diminished or eradicated. More prolonged treatment resulted in a significant clearing of the organisms from the spleens and livers, but not from the brains, of chronically infected mice.

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DE ROEVER-BONNET H. TOXOPLASMA PARASITES IN DIFFERENT ORGANS OF MICE AND HAMSTERS INFECTED WITH AVIRULENT AND VIRULENT STRAINS. Trop Geogr Med. 1964 Dec;16:337–345. [PubMed] [Google Scholar]
  2. FELDMAN H. A., MILLER L. T. Serological study of toxoplasmosis prevalence. Am J Hyg. 1956 Nov;64(3):320–335. doi: 10.1093/oxfordjournals.aje.a119845. [DOI] [PubMed] [Google Scholar]
  3. FRENKEL J. K., JACOBS L. Ocular toxoplasmosis; pathogenesis, diagnosis and treatment. AMA Arch Ophthalmol. 1958 Feb;59(2):260–279. [PubMed] [Google Scholar]
  4. GARIN J. P., EYLES D. E. Le traitement de la toxoplasmose expérimentale de la souris par la spiramycine. Presse Med. 1958 May 28;66(42):957–958. [PubMed] [Google Scholar]
  5. Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis. 1971 Dec;124(6):587–592. doi: 10.1093/infdis/124.6.587. [DOI] [PubMed] [Google Scholar]
  6. Lerner P. I. Penetration of cephalothin and lincomycin into the cerebrospinal fluid. Am J Med Sci. 1969 Feb;257(2):125–131. doi: 10.1097/00000441-196902000-00006. [DOI] [PubMed] [Google Scholar]
  7. McMaster P. R., Powers K. G., Finerty J. F., Lunde M. N. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg. 1973 Jan;22(1):14–17. doi: 10.4269/ajtmh.1973.22.14. [DOI] [PubMed] [Google Scholar]
  8. REMINGTON J. S., JACOBS L., MELTON M. L. Congenital transmission of toxoplasmosis from mother animals with acute and chronic infections. J Infect Dis. 1961 Mar-Apr;108:163–173. doi: 10.1093/infdis/108.2.163. [DOI] [PubMed] [Google Scholar]
  9. REMINGTON J. S. TOXOPLASMA AND CHRONIC ABORTION. Obstet Gynecol. 1964 Jul;24:155–157. [PubMed] [Google Scholar]
  10. Remington J. S., Cavanaugh E. N. Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med. 1965 Dec 9;273(24):1308–1310. doi: 10.1056/NEJM196512092732404. [DOI] [PubMed] [Google Scholar]
  11. Remington J. S., Efron B., Cavanaugh E., Simon H. J., Trejos A. Studies on toxoplasmosis in El Salvador. Prevalence and incidence of toxoplasmosis as measured by the Sabin-Feldman dye test. Trans R Soc Trop Med Hyg. 1970;64(2):252–267. doi: 10.1016/0035-9203(70)90132-x. [DOI] [PubMed] [Google Scholar]
  12. Remington J. S. Toxoplasmosis in the adult. Bull N Y Acad Med. 1974 Feb;50(2):211–227. [PMC free article] [PubMed] [Google Scholar]
  13. Remington J. S., Yagura T., Robinson W. S. The effect of rifampin on Toxoplasma gondii. Proc Soc Exp Biol Med. 1970 Oct;135(1):167–172. doi: 10.3181/00379727-135-35011. [DOI] [PubMed] [Google Scholar]
  14. Ruskin J., McIntosh J., Remington J. S. Studies on the mechanisms of resistance to phylogenetically diverse intracellular organisms. J Immunol. 1969 Aug;103(2):252–259. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES